Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Amortizatization of Intangibles (2022 - 2025)

Orchestra BioMed Holdings (OBIO) has disclosed Amortizatization of Intangibles for 4 consecutive years, with $289000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Amortizatization of Intangibles fell 18.82% to $289000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$166000.0, a 108.7% decrease, with the full-year FY2024 number at $654000.0, down 82.88% from a year prior.
  • Amortizatization of Intangibles was $289000.0 for Q3 2025 at Orchestra BioMed Holdings, up from $14000.0 in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.9 million in Q3 2023 to a low of -$616000.0 in Q4 2024.
  • A 4-year average of $368200.0 and a median of $158000.0 in 2023 define the central range for Amortizatization of Intangibles.
  • Peak YoY movement for Amortizatization of Intangibles: soared 1812.0% in 2023, then crashed 196.55% in 2024.
  • Orchestra BioMed Holdings' Amortizatization of Intangibles stood at $181000.0 in 2022, then surged by 252.49% to $638000.0 in 2023, then tumbled by 196.55% to -$616000.0 in 2024, then skyrocketed by 146.92% to $289000.0 in 2025.
  • Per Business Quant, the three most recent readings for OBIO's Amortizatization of Intangibles are $289000.0 (Q3 2025), $14000.0 (Q2 2025), and $147000.0 (Q1 2025).